Loss of transcriptional homeostasis of genes lacking CpG islands during aging
- Institution
- BOSTON UNIVERSITY MEDICAL CAMPUS, MA
- Principal investigator
- Samuel Beck
- Funding
- $444K
- Duration
- 2023–2026
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT Changes in chromatin architecture is a hallmark of aging. Disruption of the nuclear lamina and associated heterochromatin are commonly observed in various aging contexts, including premature aging diseases, cellular senescence, and normative aging. Although these shared structural changes have been reported for over two decades, their impact on transcription and the contribution to age-related degenerative changes remains unknown. Through computational analysis, we recently identified that CpG islands (CGIs), mammalian promoter-associated elements, provide important clues to answering this question. In humans, about 60% of genes contain CGIs at their promoters (CGI+ genes) and are broadly expressed throughout the body, while the other 40% of genes that do not have CGIs (CGI- genes) exhibit tissue-restricted expression patterns. Our preliminary results demonstrate that, in young nuclei, only CGI- genes can reside within lamina-associated heterochromatin, when transcriptionally inactive. This suggests that aging-mediated heterochromatin decondensation and lamina disruption would specifically hinder the repressive status of CGI- genes. Our data indeed show over 30% of CGI- genes are mis-activated within various aged tissues, and this pattern coincides with the loss of organ function. In this project, we will test the novel hypothesis that 1) changes in chromatin architecture during aging directly trigger uncontrolled expression of CGI- genes in tissues/contexts where they should not be expressed and this, in turn, 2) accelerates age-associated deterioration. We will also test whether the 3) pharmacological inhibition of CGI- gene misexpression delay age-related degenerative changes.
LOADING MOONBASE SCORE
Questions for BOSTON UNIVERSITY MEDICAL CAMPUS
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same institution, same topic, scored first.
- NIH · Boston University Medical Campus66
Precision Brain Health Monitoring for Alzheimer's Disease Risk Detection in the Framingham Study
Rhoda Au · $569K · 2021–2027
- NIH · Boston University Medical Campus65
Blood Biomarker Development and Validation in Chronic Traumatic Encephalopathy and Alzheimer's Disease and Alzheimer's Disease Related Dementias
Michael Alosco · $972K · 2023–2028
- NIH · Boston University Medical Campus54
Identifying Brain Epitranscriptomic Changes Associated with Alcohol Use Disorder
Huiping Zhang · $538K · 2022–2026